Physician profile
Stephanie V Mason
NPI 1700126018
$1,657.62
in general payments reported to CMS, 2019-2025
21 companies · $567 in 2025
The $567 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $188 · 2022: $307 · 2023: $296 · 2024: $298 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,161.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $361.59 | 2021-2025 | Carvykti, Rybrevant, Erleada |
| Astellas Pharma US INC | $243.91 | 2021-2024 | Myrbetriq, Xtandi |
| Ferring Pharmaceuticals INC. | $126.10 | 2024-2025 | Adstiladrin |
| Boston Scientific Corporation | $111.17 | 2022 | |
| Sumitomo Pharma America, INC. | $104.41 | 2023-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $92.65 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $84.44 | 2021-2025 | Prolaris, Myrisk |
| Blue Earth Diagnostics | $84.12 | 2021-2024 | |
| Coloplast Corp | $74.53 | 2023-2024 | Speedicath |
| Urogen Pharma, INC. | $67.29 | 2025 | |
| Hollister Incorporated | $55.55 | 2022-2023 | Infyna Chic, Vapro Plus Pocket, Vapro |
| Telix Pharmaceuticals | $45.01 | 2025 | Illuccix |
| Myovant Sciences INC. | $38.53 | 2021 | |
| Laborie Medical Technologies Corp. | $34.99 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Alnylam Pharmaceuticals INC. | $34.78 | 2023 | Oxlumo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Civco Medical Instruments | $21.39 | 2025 | |
| Immunitybio, INC. | $20.98 | 2025 | |
| Abbvie INC. | $17.19 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $15.73 | 2021 | |
| Olympus America INC. | $11.76 | 2021 | |
| Travere Therapeutics, INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.